Urovant Sciences Ltd. operates as a clinical-stage bio-pharmaceutical company. The Company focuses on developing and commercializing therapies for the treatment of urologic conditions. Urovant Sciences serves customers worldwide.

Urovant Sciences

Urovant Sciences is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions. Our lead product candidate is vibegron, an oral, once-daily, small molecule beta-3 agonist, being developed for overactive bladder (OAB), OAB in men with benign prostatic hyperplasia (BPH) and pain associated with irritable bowel syndrome (IBS). Urovant’s second investigational product candidate, URO-902, is a novel gene therapy for patients with overactive bladder (OAB) symptoms who have failed oral pharmacologic therapy.

Biotechnology Companies

Medical Organizations

Health Care Companies

Pharmaceutical Companies

Hercules Capital

Basel

Switzerland

Basel-Stadt

Basel-Stadt District (unincorporated)

London

Capital and largest city of the United Kingdom

United Kingdom

Greater London

Irvine

City in Orange County, California, United States

United States of America

Country primarily located in North America

Los Angeles metropolitan area

Metropolitan area in California, United States

California

Orange County

Capital of the canton of Zug, Switzerland

Zug District (unincorporated)

Research and Development in Biotechnology (except Nanobiotechnology)

Research and Development in the Physical, Engineering, and Life Sciences

Scientific Research and Development Services

Professional, Scientific, and Technical Services

Nursing and Residential Care Facilities

Pharmaceutical Preparation Manufacturing

Pharmaceutical and Medicine Manufacturing

Chemical Manufacturing

Manufacturing

Health Care and Social Assistance

Health Care and Social Assistance, Health

Sunovion Pharmaceuticals

Sumitovant

Sumitomo Dainippon Pharma Co.

Sunovion Pharma

Vensica Therapeutics Ltd

Commercial Physical And Biological Research

Research, Development, And Testing Services

Engineering, Accounting, Research, Management, And Related Services

Pharmaceutical Preparations

Drugs

Chemicals And Allied Products

Offices And Clinics Of Health Practitioners, Not Elsewhere Classified

Offices And Clinics Of Other Health Practitioners

Health Services

Unpkg

cdnjs

Quicklink

core-js

Fastly

Cookiebot

nginx

Google Analytics

Google Tag Manager

vimeo

drupal

gsap

Varnish

pantheon

mariadb

Biopharmaceutical

Urovant Sciences Funding & Investors

Total Amount Raised: $100,000,000

Urovant Sciences Funding Rounds

Debt Financing Investors

💸 Investors

📚 Popular Blog Posts